|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,101.45 INR | +1.11% |
|
-1.18% | +1.07% |
| 07-13 | Jenburkt Pharmaceuticals Limited Announces Address Changes | CI |
| 05-05 | Jenburkt Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 | CI |
| Market Cap | 4.22B 43.79M 38.26M 35.31M 32.55M 61.34M 62.71M 422M 166M 2.07B 164M 161M 7.11B | P/E 2024 |
11.7x | P/E 2025 | 13.9x |
|---|---|---|---|---|---|
| Enterprise Value | 4.02B 41.79M 36.52M 33.7M 31.06M 58.54M 59.84M 403M 158M 1.97B 157M 153M 6.78B | EV / Sales 2024 |
1.62x | EV / Sales 2025 | 2.82x |
| Free-Float |
38.82% | Yield 2024 |
2.22% | Yield 2025 | 1.78% |
| 1 day | +1.11% | ||
| 1 week | -1.18% | ||
| Current month | -0.74% | ||
| 1 month | -6.52% | ||
| 3 months | +7.40% | ||
| 6 months | -0.85% | ||
| Current year | +1.07% |
| 1 week | 1,081.5 |  | 1,120 |
| 1 month | 1,081.5 | | 1,154.85 |
| Current year | 944 | | 1,245 |
| 1 year | 944 | | 1,364.9 |
| 3 years | 586.9 | | 1,410 |
| 5 years | 452 | | 1,410 |
| 10 years | 243.2 | | 1,410 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2013-10-21 | |
| Director of Finance/CFO | 74 | 2013-09-23 | |
Virendra Zope
ADM | Chief Administrative Officer | - | 2025-05-11 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 2013-10-21 | |
| Director/Board Member | 74 | 2013-09-06 | |
| Director/Board Member | 63 | 2020-03-27 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.11% | -1.18% | -15.23% | +43.14% | 50.48M | |
| +0.85% | -0.80% | +52.79% | +161.33% | 1,051B | |
| +1.23% | -1.53% | +54.58% | +59.08% | 609B | |
| +0.04% | +2.58% | +34.47% | +86.33% | 450B | |
| +0.78% | -0.71% | +29.28% | +24.10% | 330B | |
| +1.41% | +0.58% | +35.44% | +40.67% | 284B | |
| -0.27% | -1.87% | +22.34% | +22.51% | 263B | |
| -1.76% | +2.37% | -20.43% | -38.00% | 223B | |
| -1.42% | +0.80% | +24.27% | +57.50% | 198B | |
| -1.48% | +3.43% | +24.08% | +71.67% | 167B | |
| Average | +0.05% | +0.37% | +24.16% | +52.83% | 357.51B | |
| Weighted average by Cap. | +0.37% | +0.02% | +37.51% | +79.63% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.42B 14.74M 12.88M 11.89M 10.96M 20.65M 21.11M 142M 55.89M 695M 55.36M 54.15M 2.39B | 1.52B 15.75M 13.77M 12.7M 11.71M 22.07M 22.56M 152M 59.72M 743M 59.16M 57.86M 2.56B |
| Net income | 260M 2.7M 2.36M 2.18M 2.01M 3.78M 3.86M 26M 10.23M 127M 10.13M 9.91M 438M | 321M 3.33M 2.91M 2.68M 2.47M 4.66M 4.77M 32.09M 12.62M 157M 12.5M 12.23M 541M |
| Net Debt | -740M -7.68M -6.71M -6.19M -5.71M -10.76M -11M -74.03M -29.12M -362M -28.85M -28.21M -1.25B | -192M -2M -1.75M -1.61M -1.49M -2.8M -2.86M -19.27M -7.58M -94.28M -7.51M -7.34M -325M |
Employees
779
Sector
Pharmaceuticals
Calendar
08-28 -
Ex-dividend date - 20.7 INR
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-17 | ₹1,101.45 | +1.11% | 428 |
| 26-07-16 | ₹1,089.40 | -0.55% | 313 |
| 26-07-15 | ₹1,095.40 | +0.32% | 471 |
| 26-07-14 | ₹1,091.90 | -0.90% | 567 |
| 26-07-13 | ₹1,101.80 | -1.15% | 479 |
- Stock Market
- Stocks
- JENBURPH6 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
